Three Reasons to Be Wary of Recently Publicized Milk Thistle Doubt
Because conflicting information about milk thistle can be confusing to those wanting to protect their liver, get the whole story about the latest study.
Continue reading »General Hepatitis C News/Updates
Milk Thistle Bolsters HCV Treatment
Nov 23, 2011
1 Comment
When it comes to slaying the "Hepatitis C dragon," two swords are better than one.
Continue reading »Hep C Trial Reports Good Results for Alisporivir
Representing a new type of Hepatitis C drug, the debut of Alisporivir (a cyclophilin inhibitor) delivers encouraging news for interferon-free Hepatitis C treatment.
Continue reading »MitoQ Could Benefit Chronic Hepatitis Patients
Nov 18, 2011
1 Comment
Antioxidants are typically advised for people with chronic hepatitis, but MitoQ takes this idea to an even greater therapeutic level.
Continue reading »Promacta Could Ease Hepatitis C Treatment Complications
Depending on the results of a study investigating Promacta for Hepatitis C blood-related treatment complications, this medication could become a valued addition to managing the side effects of Hepatitis C combination therapy.
Continue reading »Drug Thwarts Hep C Return in Transplanted Livers
In a phase 2 study, infusions of MassBiologic's human monoclonal antibody suppressed Hepatitis C resurgence in liver transplant recipients.
Continue reading »Vertex Launching 3-Month Study of Incivek
Hoping to show its ability to cure Hepatitis C in a shorter period of time, Incivek will be evaluated for its effectiveness in just 12 weeks.
Continue reading »Hepatitis C Triple Therapy Response Predicted in Four Weeks
Oct 21, 2011
12 Comments
Results from a newly published study reveal a way to predict who can be cured of Hepatitis C, providing motivation for affected individuals to complete treatment.
Continue reading »Hep C Trial Arm Added Due to Favorable PSI-7977 Data
Due to continued positive results, Pharmasset's Hepatitis C trial for PSI-7977 has been expanded to include monotherapy.
Continue reading »Companies Unite to Develop Hepatitis C and Hepatitis B Vaccines
A partnership has been formed between Inovio Pharmaceuticals and VGX International to co-develop therapeutic vaccines for both Hepatitis C and Hepatitis B.
Continue reading »
